Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) to Issue Dividend of $0.09

Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) declared a dividend on Monday, March 3rd, NASDAQ Dividends reports. Investors of record on Friday, March 14th will be given a dividend of 0.0862 per share on Monday, March 31st. The ex-dividend date is Friday, March 14th.

Brooklyn ImmunoTherapeutics Stock Down 1.0 %

BTX stock traded down $0.07 during trading on Tuesday, hitting $6.90. The company had a trading volume of 880,933 shares, compared to its average volume of 816,089. The firm has a 50-day moving average price of $1.61 and a 200-day moving average price of $1.24. Brooklyn ImmunoTherapeutics has a 12 month low of $6.66 and a 12 month high of $8.31. The stock has a market cap of $405.90 million, a price-to-earnings ratio of -3.04 and a beta of 4.61.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics in a research report on Wednesday, February 26th. They set a “hold” rating for the company.

Brooklyn ImmunoTherapeutics Company Profile

Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.